RMH - CAR-T Treatment
- Published
- 24 October 2025
- Estimated value
- £380,000
- Procedure
- Direct award
- Lots
- 1
- Notice number
- 068116-2025
- Reference
- ocds-h6vhtk-05d335
- Official source
- Official source
CPV codes
- 33600000Pharmaceutical products
Description
CAR-T treatment called Obecel developed to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r B-ALL) which has recently become available to patients. The decision which treatment is most suitable applicable to a specific age group is a clinical one that would be decided by a Multi-Disciplinary Team (MDT). The product should meet strict NHS England standards for cryogenic storage and handling and RMH has such credentials.
Official publications
- FTS · 068116-2025 · 24 October 2025
Other tenders from The Royal Marsden NHS Foundation Trust
- The provision of West London Targeted Lung Health Check Programme
- RMH - BEMS Consultancy
- RMH Emergency Lighting System Maintenance)
- Lifts Maintenance Services
- Water Management Service
- RMH - Fire Detection / Suppression / Maintenance
- EuroClonality-NDC panel
- Validation of Pharmacy Aseptic Unit
- RMH - Radiopharmaceuticals Xiel
- RMH - ACE PCR reagent rental
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is £380,000.
- Who is the buyer of this tender?
- The contracting authority is The Royal Marsden NHS Foundation Trust (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.